Proscia key facts
as of Oct 2026- Developer of a digital pathology platform designed to enhance cancer diagnosis.
- Proscia is valued at approximately $150.0M as of Oct 2026, set at its later-stage round, Mar 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $129.3M across 6 recorded rounds; the latest was Early Stage VC ($35.0M) in Mar 2025.
- Notable investors include Insight Partners (New York), Flybridge (New York), TEDCO, Hitachi Ventures, Fusion Fund — 26 tracked in total.
- Proscia has filed 8 Form Ds with the SEC since 2014, most recently Mar 2025 ($35.0M sold to 21 investors).
- Status: Privately Held (backing).
Valued at $150.0M at its later-stage round, Mar 2025. Nothing has traded since.
- ·The complete investor list: 26 names
- ·Watch Proscia: the Monday email on marks, rounds and moves
Proscia funding rounds
6 roundsWho backs Proscia
26+Proscia valuation
Proscia was valued at $150 million at its later-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Proscia raised?
Proscia has raised $129 million across 6 recorded rounds since 2017. The largest was a $927,200 seed round in Apr 2017; the most recent was a $35 million early-stage round in Mar 2025.
Proscia has filed 8 Form Ds with the SEC since 2014, most recently in Mar 2025 ($35 million sold to 21 investors).
Proscia investors
26 investors are on record for Proscia, including Insight Partners (New York), Flybridge (New York), TEDCO and Hitachi Ventures. By type, the record holds 9 venture capital firms, 3 private equity firms and 1 hedge fund. The early-stage round in Mar 2025 drew 21 investors.
About Proscia
Developer of a digital pathology platform designed to enhance cancer diagnosis. The company's platform uses computing technologies that unlock hidden data not visible to the human eye and turn that data into valuable insights, enabling physicians to improve patient outcomes and accelerate the development of life-saving advances.
- Sector
- Healthcare
- HQ
- Philadelphia, PA, United States
- Founded
- 2014
- Employees
- 129
- Website
- proscia.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.